1 year return (CAGR)
-47.04%
Mineralys Therapeutics, Inc. Common Stock Exchange (NASDAQ, USD)
MLYS
18.18
+0.57 (+2.77%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
36.22%
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
1.87B
Price/Sales
-
Ent value
1.85B
Price/Book
3.39
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 20.75 |
| Daily high | 21.23 |
| Daily low | 20.18 |
| Daily Volume | 3.20M |
| All-time high | 47.33 |
| 1y analyst estimate | 48.50 |
| Beta | 0.68 |
| EPS (TTM) | -4.13 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 18 Mar 2026 |
Downside potential
Loading...
Downside potential data
| MLYS | S&P500 | |
| Current price drop from All-time high | -61.59% | -3.00% |
| Highest price drop | -68.86% | -56.47% |
| Date of highest drop | 22 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -32.85% | -10.65% |
| Avg time to new high | 42 days | 12 days |
| Max time to new high | 626 days | 1805 days |
News
